Published in
Springer Verlag, Clinical Drug Investigation, 4(42), p. 285-300, 2022
DOI: 10.1007/s40261-022-01133-x
Links
Tools
A Developer’s Perspective on Clinical Evidence and Benefits for Rituximab Biosimilar Uptake, with a Focus on CT-P10
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 